Mr. William Stuart Marshall
United States of America
Mr. William Stuart Marshall, also known as Bill, Ph.D., is the Atlas Advisor at Atlas Venture L.P. Mr. Marshall Co-founded Miragen Therapeutics, Inc. in September 2007 and has been its Chief Executive Officer and President since September 2007. Prior to establishing miRagen, Mr. Marshall served as Vice President at Technology & Business Development for Bioscience at Thermo Fisher Scientific where he led the Thermo Fisher Biosciences Division. He served as the Executive Vice President of Research & Operations and General Manager at Fisher Scientific International. Mr. Marshall served as Executive Vice President of Research, Development & Production and Site Director at GE Healthcare Dharmacon, Inc. (a/k/a Dharmacon, Inc.). He was one of the scientific founders of Dharmacon, Inc. Mr. Marshall was instrumental in leading the chemistry, biology and bioinformatics research, which led to the development of the industry's most effective siRNA design algorithm and novel chemical modifications to enhance siRNA specificity and stability. Prior to Dharmacon, he served in several capacities at Amgen, Inc., from 1992 to 2002, as Associate Director of Research and Head of the Nucleic Acid and Peptide Technology Department. He has more than 15 years' experience in the biochemistry environment, including 10 years in industrial biotechnology. Mr. Marshall serves as a Director of FluoroFinder LLC. He has been a Director at miRagen Therapeutics, Inc. since September 2007. He serves as a Member of Business Advisory Board at AmideBio, LLC. Mr. Marshall serves as Independent Director of BiOptix Inc. He also led the development of peptide library approaches for lead discovery and development via carrier protein fusion and peptidomimetics. He is an author and co-author of 30 research papers and 10 patents. Mr. Marshall received a Bachelor of Science in Biochemistry from the University of Wisconsin-Madison and a PhD in Chemistry from the University of Colorado at Boulder.